Health Condition 1: L239- Allergic contact dermatitis, unspecified cause
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
All India Institue Of Medical Science Bathinda Punjab
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients age more than 18 years with Allergic Contact Dermatitis. 2.Those patients who developed any type of reaction at patch testing site after 48hrs or 96hrs. 3.Patients who are willing to sign the written consent form before participating in the study.
Exclusion criteria
Exclusion criteria: 1.Patients having active lesions, significant erythema or scratching over patch test site. 2.Patient with active infection at patch test site. 3.Patient with any active eczema for last 15 days. 4.Those taking oral steroids more than 15 mg prednisolone or any other immunosuppressive, or any form of treatment from last 1 month that known to influence the results of patch test. 5.Application of topical steroid or any topical anti-inflammatory at patch test result site. 6.History of Sunbathing at patch test results site and expose to UVR (Ultra violet radiation) 15 days prior to test. 7.Pregnant females and any immunocompromised patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| main role of the study is to evaluate the role of dermoscopy for the interpretation of patch test results in patients with suspected case of allergic contact dermatitis. in 72 positive reactionsTimepoint: It will be evaluate at day 2 and day 4 | — |
Secondary
| Measure | Time frame |
|---|---|
| histopathologic correlationTimepoint: at day 4 | — |
Countries
India
Contacts
Public ContactDr Shivani Bansal
All India Institue Of Medical Science
Outcome results
None listed